Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StayDry: Withdrawal Strategy for Urinary Incontinence Pharmacotherapy in Children
NCT06465576Phase 4Active, not recruiting
- Sponsor
- Aarhus University
- Start
- May 2024
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin, mirabegron in urinary incontinence (UI), sponsored by Aarhus University. Started May 2024; status: active, not recruiting.
02
Drugs
solifenacinmirabegron
03
Conditions
urinary incontinence (UI)
Beyond the preview
Go deeper on NCT06465576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06465576.